EGFR Exon 20 Insertions in NSCLC

In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on a specific subset of lung cancer: EGFR exon 20 insertion NSCLC. Joining the podcast is a distinguished panel of clinicians and lung cancer advocates:
 
Dr. Rosario Garcia Campelo, the Head of Medical Oncology and the Thoracic Tumor Unit Chair at the University Hospital A Coruna, Spain.
 
Marcia Horn, executive director of the Exon 20 Group and CEO of ICAN, the International Cancer Advocacy Network.
 
Yonsei University College of Medicine, Professor Byoung-Chul Cho, Director of the Lung Cancer Center at Yonsei Cancer Hospital in Seoul, South Korea.